Paper42930552PubMed
From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review.
Cutitaru AB and 4 others. Med Sci (Basel), 2026.
Cite this record
ConductScience Library. From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review. Papers, record 42930552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42930552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From Germ Cell Histogenesis to Precision Risk Stratification: Prognostic and Predictive Molecular Markers in Testicular Germ Cell Tumors-A Systematic Review.
- Journal
- Med Sci (Basel)
- Year
- 2026
- Publication types
- Journal Article, Systematic Review, Review
- Revised in PubMed
- 2026-10-28
Source PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasms, Germ Cell and Embryonal | Major topic |
| Testicular Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| Male | |
| Prognosis | |
| Risk Assessment | |
| MicroRNAs |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| SMIS code 351058 | The Health Programme (PS) 2021-2027 | PubMed |
Source PubMed
References115
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34446080 | The component of the m6A writer complex VIRMA is implicated in aggressive tumor phenotype, DNA damage response and cisplatin resistance in germ cell tumors. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34446080 | PubMed |
| 2 | 40146282 | Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis. | World J Urol | 2025 | https://conductscience.org/library/papers/40146282 | PubMed |
| 3 | 12697874 | Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. | J Clin Oncol | 2003 | https://conductscience.org/library/papers/12697874 | PubMed |
| 4 | 39134037 | [Testicular Germ Cell Tumours - features and prospects of the novel tumour marker microRNA-371a-3p (M371 test): a narrative review]. | Aktuelle Urol | 2024 | https://conductscience.org/library/papers/39134037 | PubMed |
| 5 | 31583686 | Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate. | Int J Cancer | 2020 | https://conductscience.org/library/papers/31583686 | PubMed |
| 6 | 33822655 | Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium. | J Clin Oncol | 2021 | https://conductscience.org/library/papers/33822655 | PubMed |
| 7 | 29898407 | Integrated Molecular Characterization of Testicular Germ Cell Tumors. | Cell Rep | 2018 | https://conductscience.org/library/papers/29898407 | PubMed |
| 8 | 35390309 | Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17. | Exp Mol Pathol | 2022 | https://conductscience.org/library/papers/35390309 | PubMed |
| 9 | 39482699 | Refractory testicular germ cell tumors are highly sensitive to the targeting of polycomb pathway demethylases KDM6A and KDM6B. | Cell Commun Signal | 2024 | https://conductscience.org/library/papers/39482699 | PubMed |
| 10 | 42202429 | Serum levels of microRNA-371a-3p (M371) for prediction of histology in chemotherapy-naïve patients with testicular germ cell tumours undergoing lymph node dissection-a retrospective analysis of 57 cases. | Urol Oncol | 2026 | https://conductscience.org/library/papers/42202429 | PubMed |
| 11 | 38633762 | The epidemiology of cryptorchidism and potential risk factors, including endocrine disrupting chemicals. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38633762 | PubMed |
| 12 | 40025812 | Induction of SOX17 with stimulation of WNT, TGF-beta, and FGF signaling drives embryonal carcinomas into the yolk-sac tumor lineage resulting in increased cisplatin resistance. | Int J Cancer | 2025 | https://conductscience.org/library/papers/40025812 | PubMed |
| 13 | 35181587 | MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer. | Cancer Genomics Proteomics | 2022 | https://conductscience.org/library/papers/35181587 | PubMed |
| 14 | 42131333 | TNFSF10: a promising prognostic biomarker and therapeutic target for immunotherapy in testicular germ cell tumors. | Front Immunol | 2026 | https://conductscience.org/library/papers/42131333 | PubMed |
| 15 | 19390421 | SALL4 is a novel diagnostic marker for testicular germ cell tumors. | Am J Surg Pathol | 2009 | https://conductscience.org/library/papers/19390421 | PubMed |
| 16 | 38541652 | RAS/Mitogen-Activated Protein Kinase Signaling Pathway in Testicular Germ Cell Tumors. | Life (Basel) | 2024 | https://conductscience.org/library/papers/38541652 | PubMed |
| 17 | 9060597 | Trophoblastic tumors of the testis other than classic choriocarcinoma: "monophasic" choriocarcinoma and placental site trophoblastic tumor: a report of two cases. | Am J Surg Pathol | 1997 | https://conductscience.org/library/papers/9060597 | PubMed |
| 18 | 40998685 | MicroRNA as a Liquid Biomarker to Detect Malignancy in Small Testicular Masses. | Eur Urol Oncol | 2025 | https://conductscience.org/library/papers/40998685 | PubMed |
| 19 | 41749828 | Comparative Analysis of the Transcriptomic Response to Cisplatin in Drug-Sensitive and Drug-Resistant Testicular Germ Cell Tumors. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749828 | PubMed |
| 20 | 27905446 | Genomic evolution and chemoresistance in germ-cell tumours. | Nature | 2016 | https://conductscience.org/library/papers/27905446 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42930552
GET https://conductscience.org/api/papers/v1/42930552/references?page=2